Recent Patents on Anti-Cancer Drug Discovery

Personal Subscription
Become EABM
Become Reviewer

Yeast-Derived β-Glucan in Combination with Anti-Tumor Monoclonal Antibody Therapy in Cancer

Volume:4   Issue: 2
Pp: 101-109
Jingjing Liu, Lacey Gunn, Richard Hansen and Jun Yan
DOI: 10.2174/157489209788452858

Ras-MAPK Pathway as a Therapeutic Target in Cancer - Emphasis on Bladder Cancer

Volume:4   Issue: 2
Pp: 125-136
Pankaj P. Dangle, Boriana Zaharieva, Hongtao Jia and Kamal S. Pohar
DOI: 10.2174/157489209788452812

Paving Roads for New Drugs in Oncology

Volume:4   Issue: 2
Pp: 137-145
Kurt S. Zaenker and Frank Entschladen
DOI: 10.2174/157489209788452795

Targeted Therapies in the Treatment of Advanced Renal Cell Carcinoma

Volume:4   Issue: 2
Pp: 146-156
Emmanuel Seront and Jean-Pascal Machiels
DOI: 10.2174/157489209788452803

Basis for Resistance to Imatinib in 16 BCR-ABL Mutants as Determined Using Molecular Dynamics

Volume:4   Issue: 2
Pp: 164-173
Tai-Sung Lee, Steven J. Potts and Maher Albitar
DOI: 10.2174/157489209788452867

Rationale for an Intraperitoneal Gemcitabine Chemotherapy Treatment for Patients with Resected Pancreatic Cancer

Volume:4   Issue: 2
Pp: 174-179
Anil Kamath, Dal Yoo, Oswald A. Stuart, Lana Bijelic and Paul H. Sugarbaker
DOI: 10.2174/157489209788452876

Patent Selections promotion: free to download

Volume:4   Issue: 2
Pp: 186-188
Bentham Science Publishers
DOI: 10.2174/157489209788452885